MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder

Completed · Phase 3 · Has a placebo group

Conditions studied: Acute Tendonitis, Bursitis

In brief

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder.

Key facts

Study ID
NCT01161615
Run by
MEDRx USA, Inc.
People needed
350
Starts
2010-07-01
Expected to finish
2011-06-01
Last updated by the study team
2018-01-17

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.